Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Shingrix: Who Needs It and Who Doesn't?
Shingrix, the only shingles vaccine now available, is recommended for routine use in adults aged ≥50 years. As with most vaccines, exceptions always seem to exist, complicating the decision-making. As they say, the devil is in the details. Let's see how “devilish” you are today, with the 4-question quiz below.
1. A 40-year-old woman with no history of varicella disease thinks she received the vaccine as a child, but no records are available. She has been diagnosed with cancer and will be starting chemotherapy in 1-2 weeks. Since immunocompromised patients are at increased risk of shingles and its complications, should this woman start her 2-dose Shingrix series?
Related Videos
Related Content
